These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36854761)

  • 1. Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A.
    Pavic K; Gupta N; Omella JD; Derua R; Aakula A; Huhtaniemi R; Määttä JA; Höfflin N; Okkeri J; Wang Z; Kauko O; Varjus R; Honkanen H; Abankwa D; Köhn M; Hytönen VP; Xu W; Nilsson J; Page R; Janssens V; Leitner A; Westermarck J
    Nat Commun; 2023 Feb; 14(1):1143. PubMed ID: 36854761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.
    Arnold HK; Sears RC
    Mol Cell Biol; 2006 Apr; 26(7):2832-44. PubMed ID: 16537924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.
    Wang J; Okkeri J; Pavic K; Wang Z; Kauko O; Halonen T; Sarek G; Ojala PM; Rao Z; Xu W; Westermarck J
    EMBO Rep; 2017 Mar; 18(3):437-450. PubMed ID: 28174209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
    Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
    EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development.
    Tinsley SL; Shelley RA; Mall GK; Chianis ERD; Dhiman A; Baral G; Kothandaraman H; Thoma MC; Daniel CJ; Lanman NA; di Magliano MP; Narla G; Solorio L; Dykhuizen EC; Sears RC; Allen-Petersen BL
    bioRxiv; 2024 May; ():. PubMed ID: 38826439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41.
    Kirchhefer U; Heinick A; König S; Kristensen T; Müller FU; Seidl MD; Boknik P
    J Biol Chem; 2014 Jan; 289(1):163-76. PubMed ID: 24225947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIP2A inhibits PP2A in human malignancies.
    Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
    Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
    Huang Q; Qin S; Yuan X; Zhang L; Ji J; Liu X; Ma W; Zhang Y; Liu P; Sun Z; Zhang J; Liu Y
    Oncol Rep; 2017 Jul; 38(1):598-606. PubMed ID: 28560452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.
    Ruvolo VR; Kurinna SM; Karanjeet KB; Schuster TF; Martelli AM; McCubrey JA; Ruvolo PP
    J Biol Chem; 2008 Dec; 283(51):35474-85. PubMed ID: 18957415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target.
    Khanna A; Pimanda JE; Westermarck J
    Cancer Res; 2013 Nov; 73(22):6548-53. PubMed ID: 24204027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart.
    Little SC; Curran J; Makara MA; Kline CF; Ho HT; Xu Z; Wu X; Polina I; Musa H; Meadows AM; Carnes CA; Biesiadecki BJ; Davis JP; Weisleder N; Györke S; Wehrens XH; Hund TJ; Mohler PJ
    Sci Signal; 2015 Jul; 8(386):ra72. PubMed ID: 26198358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B56α subunit of protein phosphatase 2A mediates retinoic acid-induced decreases in phosphorylation of endothelial nitric oxide synthase at serine 1179 and nitric oxide production in bovine aortic endothelial cells.
    Park JH; Sung HY; Lee JY; Kim HJ; Ahn JH; Jo I
    Biochem Biophys Res Commun; 2013 Jan; 430(2):476-81. PubMed ID: 23237802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1.
    Kauko O; Imanishi SY; Kulesskiy E; Yetukuri L; Laajala TD; Sharma M; Pavic K; Aakula A; Rupp C; Jumppanen M; Haapaniemi P; Ruan L; Yadav B; Suni V; Varila T; Corthals GL; Reimand J; Wennerberg K; Aittokallio T; Westermarck J
    J Biol Chem; 2020 Mar; 295(13):4194-4211. PubMed ID: 32071079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B56α subunit of PP2A is necessary for mesenchymal stem cell commitment to adipocyte.
    Hanse EA; Pan M; Liu W; Yang Y; Ishak Gabra MB; Tran TQ; Lowman XH; Ruiz B; Wang QA; Kong M
    EMBO Rep; 2021 Aug; 22(8):e51910. PubMed ID: 34232566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.
    Khanna A; Kauko O; Böckelman C; Laine A; Schreck I; Partanen JI; Szwajda A; Bormann S; Bilgen T; Helenius M; Pokharel YR; Pimanda J; Russel MR; Haglund C; Cole KA; Klefström J; Aittokallio T; Weiss C; Ristimäki A; Visakorpi T; Westermarck J
    Cancer Res; 2013 Nov; 73(22):6757-69. PubMed ID: 24072747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of PKC results in improved contractile effects and Ca
    Pluteanu F; Boknik P; Heinick A; König C; Müller FU; Weidlich A; Kirchhefer U
    Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H427-H441. PubMed ID: 35119335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel conserved mixed-isoform B56 regulatory subunit and spatiotemporal regulation of protein phosphatase 2A during Xenopus laevis development.
    Baek S; Seeling JM
    BMC Dev Biol; 2007 Dec; 7():139. PubMed ID: 18093315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear export and centrosome targeting of the protein phosphatase 2A subunit B56alpha: role of B56alpha in nuclear export of the catalytic subunit.
    Flegg CP; Sharma M; Medina-Palazon C; Jamieson C; Galea M; Brocardo MG; Mills K; Henderson BR
    J Biol Chem; 2010 Jun; 285(24):18144-54. PubMed ID: 20378546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
    Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS
    Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor suppressor phosphatase PP2A-B56α regulates stemness and promotes the initiation of malignancies in a novel murine model.
    Janghorban M; Langer EM; Wang X; Zachman D; Daniel CJ; Hooper J; Fleming WH; Agarwal A; Sears RC
    PLoS One; 2017; 12(11):e0188910. PubMed ID: 29190822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.